World Health Organisation said it has suspended a clinical trial of the
anti-malaria drug, hydroxychloroquine in coronavirus patients.
The UN agency said it did so out of safety concerns.
It said it was concerned about safety of the drug, after a study from
The Lancet revealed higher mortality rates among covid-19 patients who
took the drugs.
“The authors reported that among #COVID19 patients receiving the drug,
when used alone or with a macrolide, they estimated a higher mortality
rate”, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
He said hydroxychloroquine and chloraquine drugs are accepted as
generally safe for use in patients with autoimmune diseases or malaria.
Hydroxychloroquine has been touted by President Donald Trump as a cure for coronavirus.
He even revealed he took the medication for two weeks as prophylacti
